1. Grant Hieshima, MD Grant Hieshima, MD United States says:

    I have seen several references that say "However, based on a cross study comparison, following a single dose administration (400mg), Asian males (Japanese) have about a 2-fold higher exposure than Caucasian males.  The pharmacokinetics of dronedarone in other races has not been assessed."  Is there any rationale to decrease the dose in Asian males (Japanese)?  Does this difference reflect a genetic difference in Liver enzymes such as CYP3A4?  Is there a greater inhibition of the enzyme or possibly a relative deficiency of enzyme function in this population?   Is there any literature addressing these questions?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.